Stay updated on Avutometinib and Defactinib in Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    12 days ago
    Change Detected
    Summary
    The value on the webpage has changed from September 26, 2023, to May 13, 2024. This change likely indicates an update in medical and healthcare-related publications or documentation.
    Difference
    0.5%
    Check dated 2024-05-14T00:49:02.000Z thumbnail image
  7. Check
    19 days ago
    Change Detected
    Summary
    The classic website content has been updated to inform users that it will no longer be available as of June 25, 2024, and advises them to use the modernized ClinicalTrials.gov instead. This change may impact users monitoring medical and healthcare-related publications and documentation on the webpage.
    Difference
    0.6%
    Check dated 2024-05-07T12:54:41.000Z thumbnail image

Stay in the know with updates to Avutometinib and Defactinib in Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.